Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation. Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, potentially related to its non–antiplatelet ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Pelletier‐Galarneau, Matthieu, Hunter, Chad R. R. N., Ascah, Kathryn J., Beanlands, Rob S. B., Dwivedi, Girish, deKemp, Robert A., Chow, Benjamin J. W., Ruddy, Terrence D.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5524115/
https://ncbi.nlm.nih.gov/pubmed/28465300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.005894
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados